Cefadroxil Dosing for Uncomplicated UTI
For uncomplicated lower urinary tract infections (cystitis) in adults, cefadroxil should be dosed at 1-2 grams per day, given either as a single daily dose or divided into twice-daily dosing, for 3-7 days. 1
Recommended Dosing Regimens
The FDA-approved dosing for cefadroxil in uncomplicated cystitis offers flexibility 1:
- 1 gram once daily (single dose)
- 500 mg twice daily (divided dosing)
- 2 grams per day for all other urinary tract infections (divided twice daily)
Duration of Therapy
Treat for 3-7 days based on clinical response. Research demonstrates that 3-day regimens are as effective as 7-day courses for uncomplicated UTI 2. A randomized trial of 230 evaluable patients showed no statistically significant differences in cure rates at 1-week or 5-week follow-up between cefadroxil given for 3 days versus 7 days 2.
Clinical Context and Positioning
When to Use Cefadroxil
Cefadroxil is positioned as an alternative agent for uncomplicated cystitis, not first-line therapy. The 2011 IDSA/ESMID guidelines classify β-lactam agents (including cefadroxil and other first-generation cephalosporins like cephalexin) as appropriate choices only when other recommended agents cannot be used 3.
Key limitation: β-lactams generally have inferior efficacy and more adverse effects compared to first-line UTI antimicrobials like nitrofurantoin, trimethoprim-sulfamethoxazole, or fosfomycin 3.
First-Line Agents to Consider First
Before prescribing cefadroxil, consider these preferred options 4:
- Nitrofurantoin 100 mg twice daily for 5 days
- Fosfomycin 3 grams single dose
- Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days (if local resistance <20%)
When Cefadroxil Makes Sense
Cefadroxil is reasonable when 5:
- Patient has contraindications to first-line agents
- Pathogen is known susceptible to cephalosporins
- Fluoroquinolone-sparing approach is desired
- Treating non-ESBL-producing Enterobacteriaceae
Modern evidence supports cefadroxil's efficacy: A 2020 critical review concluded that cephalexin and cefadroxil achieve very good early bacteriological and clinical cures in uncomplicated UTI due to non-ESBL Enterobacteriaceae, comparable to many first-line agents 5. The convenient twice-daily dosing (500 mg) makes it a practical fluoroquinolone-sparing alternative 5.
Efficacy Data
Clinical trials demonstrate 6, 7:
- Cure rates: 75-100% at 5-9 days post-treatment
- Low recurrence rates across all dosing regimens
- Minimal side effects (only 3% in controlled trials)
A study of 100 patients showed cures in 75-89% across three different cefadroxil regimens (2000 mg once daily, 1000 mg once daily, or 1000 mg twice daily) with extremely low recurrence rates 6.
Important Caveats
Not for pyelonephritis: Oral β-lactams are less effective than other agents for upper tract infections 3. If used for pyelonephritis, an initial IV dose of long-acting parenteral antimicrobial (like ceftriaxone 1g) is recommended 3.
Resistance considerations: Direct susceptibility testing for cefadroxil is limited. CLSI and USCAST provide interpretive criteria for cephalexin (which can serve as a surrogate), while EUCAST provides direct cefadroxil criteria 5.
Avoid in complicated UTI: For complicated infections, cure rates drop significantly (57% vs 95% for simple UTI) 8.
Renal dosing required: Adjust dosing based on creatinine clearance to prevent drug accumulation 1:
- CrCl 25-50 mL/min: 500 mg every 12 hours
- CrCl 10-25 mL/min: 500 mg every 24 hours
- CrCl 0-10 mL/min: 500 mg every 36 hours